Inhibition of rubella virus replication by the broad-spectrum drug nitazoxanide in cell culture and in a patient with a primary immune deficiency
Review articleOpen access

Highlights•Empiric therapy with oral NTZ resulted in the elimination of RV antigen from RV positive granulomas in a PID patient.•We investigated the anti-RV activities of NTZ in cell culture and its mechanisms of action.•The drug interferes with E1-E2 intracellular trafficking and inhibits synthesis of cellular RNAs and viral RNAs.

Request full text

References (0)

Cited By (0)

No reference data.
No citation data.
Join Copernicus Academic and get access to over 12 million papers authored by 7+ million academics.
Join for free!